Annual Report Reveals 14% Revenue Decline and Shrinking Sales Force; Profit Driven by Asset Sale

summarizeSummary

Nu Skin's 2025 annual report shows a 14% revenue drop and declining sales force metrics, with net income boosted by a one-time $176.2 million asset sale, masking ongoing operational challenges.

check_boxKey Events

• Significant Revenue Decline

  Full-year 2025 revenue decreased 14% to $1.49 billion from $1.73 billion in 2024, impacted by macroeconomic pressures and foreign currency fluctuations.

• Profitability Driven by Asset Sale

  Net income for 2025 was $160.2 million (diluted EPS $3.18), a significant improvement from a $146.6 million loss in 2024, largely due to a $176.2 million pre-tax gain from the sale of the Mavely business.

• Shrinking Sales Force and Customer Base

  As of December 31, 2025, customers decreased by 10%, paid affiliates by 11%, and sales leaders by 19% compared to the prior year, indicating core business contraction.

• Ongoing Asset Impairments

  The company recorded a $25.1 million impairment charge on its BeautyBio asset group in Q1 2025, following previous goodwill impairments in 2024.

auto_awesomeAnalysis

Nu Skin's annual report for fiscal year 2025 confirms a significant 14% year-over-year revenue decline to $1.49 billion, reflecting ongoing macroeconomic pressures and a challenging direct selling environment. While the company reported a net income of $160.2 million and diluted EPS of $3.18, this positive swing from a 2024 loss was primarily driven by a substantial $176.2 million pre-tax gain from the sale of its Mavely business. This one-time event masks continued operational weakness, as evidenced by a 10% decrease in customers, an 11% drop in paid affiliates, and a 19% reduction in sales leaders. The company also recorded a $25.1 million impairment on its BeautyBio asset group, following previous goodwill impairments. The report highlights persistent regulatory scrutiny in Mainland China and risks associated with social media platforms, underscoring the challenges in its core business model. Investors should note the underlying operational struggles despite the headline profit, which was largely non-organic.